1
Clinical Trials associated with Autologous angiogenic cell precursors(TheraVitae)Autologous Stem Cell Therapy for the Treatment of Patients With Peripheral Artery Disease
Regeneration of the occluded peripheral arteries by autologous stem cell therapy is an emerging treatment modality for no-option patients with peripheral artery disease (PAD). The purpose of this study was to assess safety and efficacy of ex vivo expanded, peripheral blood-derived, autologous angiogenic cell precursors (ACPs) in no-option PAD patients.
100 Clinical Results associated with Autologous angiogenic cell precursors(TheraVitae)
100 Translational Medicine associated with Autologous angiogenic cell precursors(TheraVitae)
100 Patents (Medical) associated with Autologous angiogenic cell precursors(TheraVitae)
100 Deals associated with Autologous angiogenic cell precursors(TheraVitae)